NEXANS (EPA:NEX) | Finanzwire

BRIEF

published on 06/27/2024 at 09:05, 4 months 26 days ago

Nexans and SNCF Réseau launch an innovative superconducting current limiter

Innovation Nexans SNCF Network Superconductivity Rail
PRESS RELEASE

published on 06/27/2024 at 09:00, 4 months 26 days ago

Nexans and SNCF Réseau revolutionize rail safety with an innovative superconducting fault current limiter
Nexans and SNCF Réseau introduce a groundbreaking superconducting fault current limiter to enhance railway safety and reliability in collaboration for a more efficient rail network and energy transition

Energy Transition SNCF Réseau Nexans Superconducting Fault Current Limiter Rail Safety
BRIEF

published on 06/06/2024 at 14:30, 5 months 16 days ago

Nexans Completes Expansion of Subsea Cable Plant in Norway

Renewable Energy Energy Transition Nexans Subsea Cables Halden Plant
PRESS RELEASE

published on 06/06/2024 at 14:25, 5 months 16 days ago

Nexans finalizes expansion of world-class subsea cable facility in Norway to address global demand
Nexans officially opens newly expanded subsea cable plant in Halden, Norway to meet global demand for electrification and energy transition

Energy Transition Norway Nexans Subsea Cable Halden
BRIEF

published on 06/04/2024 at 15:05, 5 months 18 days ago

Nexans Announces Share Capital and Voting Rights Update for May 2024

Share Capital Voting Rights AMF Regulations Reporting Nexans
PRESS RELEASE

published on 06/04/2024 at 15:00, 5 months 18 days ago

Information on share capital and voting rights - May 2024
Nexans S.A. provides statement on share capital and voting rights as of May 2024 in accordance with French regulations. Total number of voting rights disclosed

Share Capital Voting Rights French Regulations May 2024 Nexans S.A.
BRIEF

published on 05/16/2024 at 18:39, 6 months 6 days ago

Combined General Meeting of Nexans shareholders in 2024

Dividend General Assembly Auditors Independent Directors Nexans
PRESS RELEASE

published on 05/16/2024 at 18:34, 6 months 6 days ago

Nexans Mixed Shareholders’ Meeting of May 16th, 2024
Nexans Annual Shareholders' Meeting on May 16th, 2024 approved all 24 resolutions, including a 10% dividend increase and new board appointments. Meeting details available on Nexans website

Dividend Increase Board Appointments Annual Shareholders' Meeting Nexans Sustainability Information

Published on 11/22/2024 at 23:55, 9 hours 31 minutes ago

Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 9 hours 56 minutes ago

Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 10 hours 21 minutes ago

Kidoz Inc. Announces Results of 2024 AGM
Published on 11/22/2024 at 23:05, 10 hours 21 minutes ago

Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 10 hours 56 minutes ago

Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.

View all ACCESSWIRE

Published on 11/22/2024 at 18:14, 15 hours 11 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 18:00, 15 hours 26 minutes ago

Holding(s) in Company
Published on 11/22/2024 at 17:53, 15 hours 32 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 16 hours 30 minutes ago

EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 17 hours 26 minutes ago

Proposed cancellation of admission to trading

View all EQS

Published on 11/22/2024 at 14:35, 18 hours 51 minutes ago

Thales Press release
Published on 11/21/2024 at 06:58, 2 days 2 hours ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 14 hours ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 15 hours ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 15 hours ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024

View all LES ECHOS COMFI WIRE

News